← APIs / ClinicalIntelPulse
Verified

ClinicalIntelPulse

PulseNetworkby PulseNetwork · Intelligence APIs, Data, AI Agents

The medical intelligence layer for AI agents. Consumer lane: plain-language drug info, drug-drug interaction screening, and recall checks from FDA-approved labels (drug-check, interaction-check, recall-check). Institutional lane: pharmaceutical pipeline and clinical-trial intelligence from 400,000+ ClinicalTrials.gov studies, FDA OpenFDA, and PubMed. 13 endpoints, from $0.10. Pay-per-query via x402 micropayments on Base.

aifederated
Price per request
$0.02
About

The medical intelligence layer for AI agents. Consumer lane: plain-language drug info, drug-drug interaction screening, and recall checks from FDA-approved labels (drug-check, interaction-check, recall-check). Institutional lane: pharmaceutical pipeline and clinical-trial intelligence from 400,000+ ClinicalTrials.gov studies, FDA OpenFDA, and PubMed. 13 endpoints, from $0.10. Pay-per-query via x402 micropayments on Base. Part of PulseNetwork, operated by The Aslan Group LLC. Apiosk indexes this federated listing and adds ref=apiosk for attribution; calls and x402 payments go directly to PulseNetwork.

Hosted by the provider

Apiosk lists this API but does not proxy it. Call the provider's URL directly and pay them over x402 — Apiosk never sits between you and the response.

Open provider →

ResourceDescription
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-check?ref=apiosk ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, enrollment, dates, countries) or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API — no LLM, no key, public domain. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/pipeline-scan?ref=apiosk Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?ref=apiosk FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel?ref=apiosk Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape?ref=apiosk Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-brief?ref=apiosk Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/mechanism-map?ref=apiosk Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials?ref=apiosk Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/failure-analysis?ref=apiosk Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/patient-finder?ref=apiosk Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal?ref=apiosk Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/drug-check?ref=apiosk What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes. For patient, caregiver, pharmacy, and health-assistant agents. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/interaction-check?ref=apiosk Can these medications be taken together? Cross-references the FDA-approved drug-interaction and contraindication sections for 2+ drugs and flags possible interactions in plain language, with severity and what-to-do. For patient, caregiver, pharmacy, and health-assistant agents managing a medication list. Open
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/recall-check?ref=apiosk Is my medication recalled? Checks the FDA enforcement database for active and past recalls of a drug, explains the recall class (I/II/III) in plain language, and lays out what to do. For patient, caregiver, pharmacy, and health-assistant agents. Open
Technical Specs
Auth MethodNone (x402 payment proof only)
Response FormatJSON
Endpoints14
Endpoints
MethodPathDescriptionCost
GET /api/clinical/approval-outlook FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.
$0.25 default
 View details
GET /api/clinical/deal-signal Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.
$0.35 default
 View details
GET /api/clinical/disease-landscape Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents.
$0.35 default
 View details
GET /api/clinical/drug-check What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes. For patient, caregiver, pharmacy, and health-assistant agents.
$0.10 default
 View details
GET /api/clinical/failure-analysis Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.
$0.20 default
 View details
GET /api/clinical/global-trials Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.
$0.15 default
 View details
GET /api/clinical/interaction-check Can these medications be taken together? Cross-references the FDA-approved drug-interaction and contraindication sections for 2+ drugs and flags possible interactions in plain language, with severity and what-to-do. For patient, caregiver, pharmacy, and health-assistant agents managing a medication list.
$0.15 default
 View details
GET /api/clinical/mechanism-map Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.
$0.20 default
 View details
GET /api/clinical/patient-finder Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.
$0.10 default
 View details
GET /api/clinical/pipeline-scan Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents.
$0.15 default
 View details
GET /api/clinical/recall-check Is my medication recalled? Checks the FDA enforcement database for active and past recalls of a drug, explains the recall class (I/II/III) in plain language, and lays out what to do. For patient, caregiver, pharmacy, and health-assistant agents.
$0.10 default
 View details
GET /api/clinical/sponsor-intel Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.
$0.20 default
 View details
GET /api/clinical/trial-brief Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents.
$0.10 default
 View details
GET /api/clinical/trial-check ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, enrollment, dates, countries) or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API — no LLM, no key, public domain.
$0.02 default
 View details
Endpoint documentation
GET/api/clinical/approval-outlook
$0.25 default
Description

FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.

Documentation

FDA/EMA approval probability

Approval probability for drugs in a disease area — PDUFA calendar, completed trial data, regulatory designations, historical success rates. Data: ClinicalTrials.gov + FDA OpenFDA + PDUFA synthesis.

**Price:** $0.25 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.25 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "agency": {
      "default": "both",
      "enum": [
        "FDA",
        "EMA",
        "both"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "horizon": {
      "default": "18m",
      "enum": [
        "12m",
        "18m",
        "24m"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/deal-signal
$0.35 default
Description

Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.

Documentation

Biotech M&A and licensing deal signals

Acquisition targets with estimated deal values, recent deal comps (named transactions + dollar values), most likely acquirers, deal timing signals, valuation framework, red flags.

**Price:** $0.35 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.35 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "deal_type": {
      "default": "both",
      "enum": [
        "acquisition",
        "licensing",
        "both"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "stage": {
      "default": "both",
      "enum": [
        "phase2",
        "phase3",
        "both"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/disease-landscape
$0.35 default
Description

Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents.

Documentation

Full disease landscape report

Comprehensive disease brief — approved drugs, mechanism landscape (crowded/gaps), Phase 2-3 pipeline, PDUFA calendar, M&A deal activity, opportunity score (0-100), investment thesis. Replaces Evaluate Pharma/Citeline.

**Price:** $0.35 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.35 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "depth": {
      "default": "standard",
      "enum": [
        "standard",
        "deep"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/drug-check
$0.10 default
Description

What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes. For patient, caregiver, pharmacy, and health-assistant agents.

Documentation

What is this medication? (plain language)

Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes. Data: FDA openFDA drug label.

**Price:** $0.1 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.10 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "drug": {
      "description": "Brand or generic medication name — e.g. 'Ozempic' | 'metformin' | 'ibuprofen'",
      "required": true,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [
    "drug"
  ],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/failure-analysis
$0.20 default
Description

Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.

Documentation

Clinical trial failure analysis

Phase 2→3 and Phase 3→approval success rates, failure taxonomy (wrong hypothesis/patient/endpoint/dose/safety), named failed trials, lessons learned, successful design principles, biomarker strategy.

**Price:** $0.2 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.20 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/global-trials
$0.15 default
Description

Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.

Documentation

Global clinical trial landscape

International distribution across WHO ICTRP registries — ChiCTR/China, CTRI/India, UMIN/Japan, REBEC/Brazil, ANZCTR/Australia, KCT/Korea, and 10+ more. Regional regulatory landscape, unmet needs, development finance context.

**Price:** $0.15 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.15 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "region": {
      "default": "global",
      "enum": [
        "global",
        "africa",
        "asia",
        "europe",
        "latin-america",
        "middle-east",
        "north-america"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/interaction-check
$0.15 default
Description

Can these medications be taken together? Cross-references the FDA-approved drug-interaction and contraindication sections for 2+ drugs and flags possible interactions in plain language, with severity and what-to-do. For patient, caregiver, pharmacy, and health-assistant agents managing a medication list.

Documentation

Can these medications be taken together?

Cross-references the FDA-approved drug-interaction and contraindication sections for 2+ drugs and flags possible interactions in plain language, with severity and what-to-do. Data: FDA openFDA drug label.

**Price:** $0.15 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.15 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "drugs": {
      "description": "Two to eight medication names, comma-separated — e.g. 'warfarin,ibuprofen'",
      "required": true,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [
    "drugs"
  ],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/mechanism-map
$0.20 default
Description

Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.

Documentation

Drug target and MOA landscape

Approved mechanisms, pipeline targets by phase, first-in-class opportunities, white spaces (validated biology, no agent), modality breakdown, combination landscape. Data: ClinicalTrials.gov + PubMed + synthesis.

**Price:** $0.2 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.20 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "mechanism": {
      "description": "Optional focus — e.g. 'BTK inhibitor' | 'CAR-T' | 'IL-17'",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/patient-finder
$0.10 default
Description

Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.

Documentation

Recruiting trial finder (plain language)

Patient-friendly finder — recruiting trials with plain-language summaries, accessible eligibility, step-by-step application guide, patient advocacy resources. Global coverage. Data: ClinicalTrials.gov v2.

**Price:** $0.1 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.10 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "country": {
      "description": "Optional country filter — e.g. 'United States' | 'Germany' | 'Australia'",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "phase": {
      "default": "any",
      "enum": [
        "phase2",
        "phase3",
        "any"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/pipeline-scan
$0.15 default
Description

Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents.

Documentation

Phase 2/3 pipeline scan

All active Phase 2/3 trials for any disease globally — trial counts, sponsor landscape, geographic distribution, mechanism breakdown, pipeline density assessment. Data: ClinicalTrials.gov v2 (no API key required).

**Price:** $0.15 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.15 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "phase": {
      "default": "both",
      "enum": [
        "phase2",
        "phase3",
        "both"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "status": {
      "default": "active",
      "enum": [
        "active",
        "all"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/recall-check
$0.10 default
Description

Is my medication recalled? Checks the FDA enforcement database for active and past recalls of a drug, explains the recall class (I/II/III) in plain language, and lays out what to do. For patient, caregiver, pharmacy, and health-assistant agents.

Documentation

Is my medication recalled?

Checks the FDA enforcement database for active and past recalls of a drug, explains the recall class (I/II/III) in plain language, and lays out what to do. Data: FDA openFDA enforcement.

**Price:** $0.1 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.10 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "drug": {
      "description": "Brand or generic medication name — e.g. 'metformin' | 'valsartan'",
      "required": true,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [
    "drug"
  ],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/sponsor-intel
$0.20 default
Description

Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.

Documentation

Pharma/biotech pipeline intelligence

Pipeline by phase, FDA approval history, Phase 3 assets with peak sales estimates, partnerships, investment signals for any company. Data: ClinicalTrials.gov + FDA OpenFDA + news synthesis.

**Price:** $0.2 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.20 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "focus": {
      "default": "all",
      "enum": [
        "pipeline",
        "approvals",
        "deals",
        "all"
      ],
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "sponsor": {
      "description": "Company name — e.g. 'Moderna' | 'Alnylam' | 'Vertex Pharmaceuticals'",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/trial-brief
$0.10 default
Description

Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents.

Documentation

Clinical trial deep dive by NCT ID

Full trial design, endpoints, eligibility, enrollment, geographic footprint, outcome summary for any trial by NCT ID. Data: ClinicalTrials.gov v2 + PubMed.

**Price:** $0.1 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.10 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "nct_id": {
      "description": "NCT identifier — e.g. NCT04368728",
      "required": true,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [
    "nct_id"
  ],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
GET/api/clinical/trial-check
$0.02 default
Description

ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, enrollment, dates, countries) or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API — no LLM, no key, public domain.

Documentation

ClinicalTrials.gov lookup — single trial by NCT id or filtered search, deterministic

Trial status, phase, sponsor, enrollment, dates and countries by NCT id, or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API. No LLM, public domain.

**Price:** $0.02 USDC per call

Calls go directly to PulseNetwork. Paid routes use the live x402 challenge; Apiosk never rewrites payTo or settles the payment.

Pricing
$0.02 default
Authentication

No account or API key. Pay PulseNetwork directly using the live x402 challenge. The challenge is authoritative for price, network, asset and payTo.

Parameters
{
  "properties": {
    "condition": {
      "description": "Search by condition",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "limit": {
      "description": "1-25, default 10",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "nct": {
      "description": "Single trial by NCT id, e.g. NCT02142738",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "phase": {
      "description": "1|2|3|4",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "sponsor": {
      "description": "Search by sponsor",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    },
    "status": {
      "description": "RECRUITING | COMPLETED | ...",
      "required": false,
      "type": "string",
      "x-parameter-location": "query"
    }
  },
  "required": [],
  "type": "object"
}
Links
External documentation ↗OpenAPI / Swagger ↗
Home · Documentation · Apiosk.com